248 related articles for article (PubMed ID: 26844698)
1. Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL.
Le Pen J; Maillet L; Sarosiek K; Vuillier C; Gautier F; Montessuit S; Martinou JC; Letaï A; Braun F; Juin PP
Cell Death Dis; 2016 Feb; 7(2):e2083. PubMed ID: 26844698
[TBL] [Abstract][Full Text] [Related]
2. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
Zhang J; Huang K; O'Neill KL; Pang X; Luo X
Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
[TBL] [Abstract][Full Text] [Related]
3. B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.
Renault TT; Elkholi R; Bharti A; Chipuk JE
J Biol Chem; 2014 Sep; 289(38):26481-26491. PubMed ID: 25096574
[TBL] [Abstract][Full Text] [Related]
4. Bcl-xL stimulates Bax relocation to mitochondria and primes cells to ABT-737.
Renault TT; Teijido O; Missire F; Ganesan YT; Velours G; Arokium H; Beaumatin F; Llanos R; Athané A; Camougrand N; Priault M; Antonsson B; Dejean LM; Manon S
Int J Biochem Cell Biol; 2015 Jul; 64():136-46. PubMed ID: 25862283
[TBL] [Abstract][Full Text] [Related]
5. Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells.
Aranovich A; Liu Q; Collins T; Geng F; Dixit S; Leber B; Andrews DW
Mol Cell; 2012 Mar; 45(6):754-63. PubMed ID: 22464442
[TBL] [Abstract][Full Text] [Related]
6. Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.
Gautier F; Guillemin Y; Cartron PF; Gallenne T; Cauquil N; Le Diguarher T; Casara P; Vallette FM; Manon S; Hickman JA; Geneste O; Juin P
Mol Cell Biol; 2011 Feb; 31(4):832-44. PubMed ID: 21173168
[TBL] [Abstract][Full Text] [Related]
7. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets.
Kodama T; Takehara T; Hikita H; Shimizu S; Shigekawa M; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Yin XM; Hayashi N
J Biol Chem; 2011 Apr; 286(16):13905-13. PubMed ID: 21367852
[TBL] [Abstract][Full Text] [Related]
8. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological blockade of Bcl-2, Bcl-x(L) and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice.
Grabow S; Waring P; Happo L; Cook M; Mason KD; Kelly PN; Strasser A
Cell Death Differ; 2012 Apr; 19(4):623-32. PubMed ID: 21997189
[TBL] [Abstract][Full Text] [Related]
10. Bcl-xL controls a switch between cell death modes during mitotic arrest.
Bah N; Maillet L; Ryan J; Dubreil S; Gautier F; Letai A; Juin P; Barillé-Nion S
Cell Death Dis; 2014 Jun; 5(6):e1291. PubMed ID: 24922075
[TBL] [Abstract][Full Text] [Related]
11. A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2.
Renault TT; Dejean LM; Manon S
Mech Ageing Dev; 2017 Jan; 161(Pt B):201-210. PubMed ID: 27112371
[TBL] [Abstract][Full Text] [Related]
12. Hypertonicity-imposed BCL-XL addiction primes colorectal cancer cells for death.
Heimer S; Knoll G; Steixner C; Calance DN; Trinh DT; Ehrenschwender M
Cancer Lett; 2018 Oct; 435():23-31. PubMed ID: 30075205
[TBL] [Abstract][Full Text] [Related]
13. BH3-only protein bid participates in the Bcl-2 network in healthy liver cells.
Hikita H; Takehara T; Kodama T; Shimizu S; Hosui A; Miyagi T; Tatsumi T; Ishida H; Ohkawa K; Li W; Kanto T; Hiramatsu N; Hennighausen L; Yin XM; Hayashi N
Hepatology; 2009 Dec; 50(6):1972-80. PubMed ID: 19839062
[TBL] [Abstract][Full Text] [Related]
14. Interactions of pro-apoptotic BH3 proteins with anti-apoptotic Bcl-2 family proteins measured in live MCF-7 cells using FLIM FRET.
Liu Q; Leber B; Andrews DW
Cell Cycle; 2012 Oct; 11(19):3536-42. PubMed ID: 22895112
[TBL] [Abstract][Full Text] [Related]
15. Nutrient Starvation Sensitizes Human Ovarian Cancer SKOV3 Cells to BH3 Mimetic via Modulation of Mitochondrial Dynamics.
Wang S; Mao Y; Xi S; Wang X; Sun L
Anat Rec (Hoboken); 2017 Feb; 300(2):326-339. PubMed ID: 27486855
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis.
Pujals A; Renouf B; Robert A; Chelouah S; Hollville E; Wiels J
Cell Death Dis; 2011 Jul; 2(7):e184. PubMed ID: 21796156
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737.
Stauffer SR
Curr Top Med Chem; 2007; 7(10):961-5. PubMed ID: 17508927
[TBL] [Abstract][Full Text] [Related]
18. The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53.
Reuland SN; Goldstein NB; Partyka KA; Cooper DA; Fujita M; Norris DA; Shellman YG
PLoS One; 2011; 6(8):e24294. PubMed ID: 21897876
[TBL] [Abstract][Full Text] [Related]
19. The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production.
Bessou M; Lopez J; Gadet R; Deygas M; Popgeorgiev N; Poncet D; Nougarède A; Billard P; Mikaelian I; Gonzalo P; Rimokh R; Gillet G
Oncogene; 2020 Apr; 39(15):3056-3074. PubMed ID: 32066881
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal helix of Bcl-x(L) mediates Bax retrotranslocation from the mitochondria.
Todt F; Cakir Z; Reichenbach F; Youle RJ; Edlich F
Cell Death Differ; 2013 Feb; 20(2):333-42. PubMed ID: 23079612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
